project id: TCGA-LGG; case submitter id: TCGA-P5-A5EX; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.24; rna integrity number: 7.9; age at index: 41; days to birth: -15091; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1971; age at diagnosis: 15091; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 243.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9451/3; primary diagnosis: Oligodendroglioma, anaplastic; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 65; initial weight: 280.0; sample id: 865f4ef4-4d1c-4cea-a6de-ce7901dea213; sample submitter id: TCGA-P5-A5EX-01A; portion id: 462543e8-af36-486f-9f0d-3b604526bae7; portion submitter id: TCGA-P5-A5EX-01A-12; slide id: bf94a5c3-edef-48a4-97a1-64e6dbd72e08; slide submitter id: TCGA-P5-A5EX-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 60.0; percent tumor cells: 30.0; percent tumor nuclei: 70.0; section location: TOP;